BackCorcept Therapeutics Overview

Corcept Therapeutics Total Revenue

Revenue analysis for CORT.

Quarterly Revenue

$164.90M
↑ 4.89% YoY

As of Mar 2026

Annual Revenue (TTM)

$769.10M
↑ 12.2% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin